A Multicenter Study for Evaluating a Digital Support System in Childhood Obesity Treatment

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-17
SponsorKarolinska Institutet

About this trial

Evira is a digital support system newly developed for treatment of childhood obesity. Through daily weighings at home using a special scale together with a message function in the Evira application, enabling fast and easy communication with the clinic, parents and the clinicians can easily follow the child's weight development. The purpose of this randomized controlled study is to evaluate the effect of adding Evira to the already locally used life-style treatment of childhood obesity.

Eligibility criteria

Qualifiers

Age >4.0 and <17.0 years of age at inclusion

Obesity defined based on the International Obesity Task Force criteria iso-BMI 30 - 40 kg/m2

Willingness to participate in an obesity treatment clinical trial

Family ability to communicate in the language of the country of residence e.g. write and read messages in the mobile application

Disqualifiers

Morbid obesity defined as iso-BMI>40kg/m2 independently of age

Endocrine disorders other than well controlled hypothyroidism

Metabolic disorders of importance for weight control - to be discussed

Treatment for depression and other psychiatric disorders during the last 6 months before inclusion

Trial design

Treatments tested in this trial

  • Evira Care treatment
  • Standard Lifestyle Care

Treatment groups

680 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Karolinska Institutet

Lead sponsor

Lund University

Collaborator

Evira AB

Collaborator